menu search

Waste connections: pricing power, margin improvement initiatives drive a positive business outlook

Despite a decline in volume, WCN reported strong 2Q23 results with impressive price increases outpacing competitors. WCN's focus on shedding low-margi...

September 12, 2023, 12:21 am

arrowhead: biotech innovation on display

arrowhead is a promising biotech company with a strong platform and pipeline of drugs targeting various...

June 6, 2023, 11:55 am

Salona global closes acquisition of arrowhead medical, provides update on biodex integration; posts first quarter results with positive adjusted ebitda, 23% annual revenue growth and 27% growth in ann

SAN DIEGO, May 16, 2023 (GLOBE NEWSWIRE) — Salona Global Medical Device Corporation (“Salona Global”, “SGMD” or the ‎‎“Company”) (TS...

May 16, 2023, 11:30 am

arrowhead pharmaceuticals, inc. (arwr) q2 2023 earnings call transcript

arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q2 2023 Earnings Conference Call May 2, 2023 4:30 PM ET ...

May 2, 2023, 8:42 pm

arrowhead pharmaceuticals shares rise on positive interim trial results

arrowhead Pharmaceuticals has released positive interim results from its Phase 1/2 study of its investi...

April 25, 2023, 11:07 am

arrowhead pharmaceuticals to webcast fiscal 2023 second quarter results

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announ...

April 18, 2023, 7:30 am

Is arrowhead pharmaceuticals a buy now?

arrowhead Pharmaceuticals recently received a rating upgrade from SVB Financial and a price target that...

April 16, 2023, 5:21 am

arrowhead pharmaceuticals to present at 43rd annual cowen health care conference

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announ...

March 3, 2023, 7:30 am

arrowhead pharmaceuticals requires caution

arrowhead Pharmaceuticals, Inc. is a company with strong potential. However, it has yet to conclusively...

February 23, 2023, 2:19 pm

arrowhead pharmaceuticals, inc. (arwr) q1 2023 earnings call transcript

arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q1 2023 Earnings Conference Call February 6, 2023 4:30 P...

February 6, 2023, 9:14 pm

arrowhead pharmaceuticals to present at 41st annual j.p. morgan healthcare conference

PASADENA, Calif.--( BUSINESS WIRE )--arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that...

December 21, 2022, 4:00 pm

arrowhead pharmaceuticals: good work in progress

arrowhead is a strong biotech with unique and powerful attributes. The company has seen its share of re...

December 21, 2022, 12:29 pm

arrowhead pharmaceuticals surges after hinting at a midstage win in liver disease

arrowhead provided a bullish update for its midstage liver disease treatment on Monday, pushing ARWR st...

November 29, 2022, 12:01 pm

arrowhead pharmaceuticals, inc. (arwr) q4 2022 earnings call transcript

arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q4 2022 Earnings Conference Call November 28, 2022 4:30 ...

November 28, 2022, 8:44 pm

Royalty pharma agrees to acquire royalty interest in olpasiran from arrowhead for $250 million and future milestones

Olpasiran is an siRNA therapeutic being developed by Amgen to reduce risk of cardiovascular disease arrowhead<...

November 9, 2022, 1:49 pm

arrowhead pharmaceuticals, inc. (arwr) ceo christopher anzalone on q3 2022 results - earnings call transcript

arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q3 2022 Results Conference Call August 4, 2022 5:00 PM E...

August 4, 2022, 9:59 pm

Ncs multistage holdings, inc. (ncsm) ceo robert nipper on q2 2022 results - earnings call transcript

NCS Multistage Holdings, Inc. (NASDAQ:NCSM ) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Ryan Hummer - Chief Finan...

August 2, 2022, 9:51 am

arrowhead pharmaceuticals: an rnai name to know

Shares of RNA interference concern arrowhead Pharmaceuticals are down over 50% since making an all-time...

July 28, 2022, 3:45 pm

arrowhead pharma: we can afford to wait for more proof

arrowhead is a leader in RNAi. ARWR has a vast platform....

June 28, 2022, 11:17 am

arrowhead pharmaceuticals, inc. (arwr) ceo christopher anzalone on q2 2022 results - earnings call transcript

arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q2 2022 Earnings Conference Call May 10, 2022 4:30 PM ET...

May 10, 2022, 9:57 pm


Search within

Pages Search Results: